To further assess whether NanoString‐based gene profiling can readily differentiate between anti‐TIF‐1γ+‐ and anti‐Mi‐2+‐associated DM, we performed a pathway score analysis, which functionally annotated groups of genes followed by unsupervised clustering of samples. The gene discussed is TRIM33; the disease is dermatomyositis.